These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25586662)

  • 21. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
    Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma.
    Gröbe A; Hanken H; Kluwe L; Schöllchen M; Tribius S; Pohlenz P; Clauditz T; Grob T; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2013 Oct; 42(9):676-81. PubMed ID: 23721566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of histopathological and immunohistochemical differences of oral squamous cell carcinoma in young and old patients in Sri Lanka.
    Siriwardena BS; Tilakaratne A; Amaratunga EA; Udagama MN; Ogawa I; Kudo Y; Takata T; Tilakaratne WM
    J Oral Pathol Med; 2007 Jul; 36(6):357-62. PubMed ID: 17559498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma.
    Maruse Y; Kawano S; Jinno T; Matsubara R; Goto Y; Kaneko N; Sakamoto T; Hashiguchi Y; Moriyama M; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Kiyoshima T; Nakamura S
    Int J Oral Maxillofac Surg; 2018 Jul; 47(7):836-845. PubMed ID: 29395669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
    Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
    Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas.
    Wehrhan F; Büttner-Herold M; Distel L; Ries J; Moebius P; Preidl R; Geppert CI; Neukam FW; Kesting M; Weber M
    BMC Cancer; 2018 Aug; 18(1):823. PubMed ID: 30115022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.
    Zaid KW
    Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic implications of malignancy grading of invasive fronts of oral squamous cell carcinoma.
    Sharma P; Wadhwan V
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S835-S840. PubMed ID: 38384063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectin-1, -3 and -7.
    Cludts S; Decaestecker C; Mahillon V; Chevalier D; Kaltner H; André S; Remmelink M; Leroy X; Gabius HJ; Saussez S
    Anticancer Res; 2009 Dec; 29(12):4933-40. PubMed ID: 20044599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathological grading systems analysis of oral squamous cell carcinomas of young patients.
    Frare JC; Sawazaki-Calone I; Ayroza-Rangel AL; Bueno AG; de Morais CF; Nagai HM; Kunz R; Lopes MA
    Med Oral Patol Oral Cir Bucal; 2016 May; 21(3):e285-98. PubMed ID: 26946200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system.
    Boxberg M; Jesinghaus M; Dorfner C; Mogler C; Drecoll E; Warth A; Steiger K; Bollwein C; Meyer P; Wolff KD; Kolk A; Weichert W
    Histopathology; 2017 Jun; 70(7):1125-1137. PubMed ID: 28122134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
    Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
    Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
    Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
    Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-7 as a potential predictive marker of chemo- and/or radio-therapy resistance in oral squamous cell carcinoma.
    Matsukawa S; Morita K; Negishi A; Harada H; Nakajima Y; Shimamoto H; Tomioka H; Tanaka K; Ono M; Yamada T; Omura K
    Cancer Med; 2014 Apr; 3(2):349-61. PubMed ID: 24515895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis.
    Long B; Yu Z; Zhou H; Ma Z; Ren Y; Zhan H; Li L; Cao H; Jiao Z
    Int J Surg; 2018 Aug; 56():242-249. PubMed ID: 29940258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging and grading of oral squamous cell carcinoma: An update.
    Almangush A; Mäkitie AA; Triantafyllou A; de Bree R; Strojan P; Rinaldo A; Hernandez-Prera JC; Suárez C; Kowalski LP; Ferlito A; Leivo I
    Oral Oncol; 2020 Aug; 107():104799. PubMed ID: 32446214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of PD-L2 expression in patients with oral squamous cell carcinoma-A comparison to the PD-L1 expression profile.
    Weber M; Wehrhan F; Baran C; Agaimy A; Büttner-Herold M; Kesting M; Ries J
    Cancer Med; 2019 Mar; 8(3):1124-1134. PubMed ID: 30659749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proliferative Index in Invasive Tumor Front of Oral Squamous Cell Carcinoma: A Potential Prognostic Indicator.
    Bhuyan L; Sarangi S; Das BK; Das SN; Nayak S
    J Contemp Dent Pract; 2018 Feb; 19(2):170-176. PubMed ID: 29422466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of Phosphohistone H3 as a cell proliferation marker in oral squamous cell carcinoma. A comparative study with Ki-67 and the mitotic activity index.
    Tancredi-Cueto N; Vigil-Bastitta G; Bologna-Molina R; Beovide-Cortegoso V
    Med Oral Patol Oral Cir Bucal; 2022 Sep; 27(5):e444-e451. PubMed ID: 35975799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.